• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SUZUKI SHIRO  鈴木 史朗

ORCIDConnect your ORCID iD *help
… Alternative Names

SUZUKI Shiro  鈴木 史朗

Less
Researcher Number 20612758
Other IDs
Affiliation (Current) 2025: 愛知県がんセンター(研究所), 腫瘍免疫制御TR分野, 研究員
Affiliation (based on the past Project Information) *help 2021: 愛知県がんセンター(研究所), 婦人科部, 部長
2019 – 2021: 愛知県がんセンター(研究所), 腫瘍免疫応答研究分野, 研究員
2019: 愛知県がんセンター(研究所), 婦人科, 部長
2019: 愛知県がんセンター(研究所), 婦人科部, 部長
2015 – 2018: 名古屋大学, 医学部附属病院, 講師
2012 – 2014: 名古屋大学, 医学部附属病院, 助教
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Except Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
腫瘍免疫 / 婦人科がん / 子宮体がん / 腹膜播種 / 卵巣がん / 婦人科腫瘍 / 悪性卵巣腫瘍
Except Principal Investigator
卵巣癌 / エクソソーム / 婦人科がん … More / 腫瘍免疫 / mesothelium / miRNA / ovarian cancer / exosome / 細胞外小胞 / マイクロRNA / 中皮細胞 / 卵巣がん / 細胞間相互作用 / がん微小環境 / 腹膜微小環境 / メタボローム解析 / エクソソーム解析 / 卵巣癌関連腹膜中皮 / トランスクリプトーム解析 / 癌関連腹膜中皮 / 薬剤耐性 / 癌性腹膜炎 / 癌関連腹膜中皮細胞 / 化学療法抵抗性 / 腹膜中皮細胞 / 腹膜播種 / TIL / PDXモデル / 免疫療法 / 腫瘍浸潤リンパ球 / 腫瘍免疫療法 Less
  • Research Projects

    (7 results)
  • Research Products

    (106 results)
  • Co-Researchers

    (15 People)
  •  Antitumor immune response in patients with endometrial cancer from the perspective of uterine EcosystemPrincipal Investigator

    • Principal Investigator
      Suzuki Shiro
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Aichi Cancer Center Research Institute
  •  Elucidation of malignancy, peritoneal dissemination and spread mechanism of ovarian cancer by interaction with peritoneal mesothelium.

    • Principal Investigator
      Kikkawa Fumitaka
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Nagoya University
  •  Interdisciplinary research on intraperitoneal cell-to-cell crosstalk focusing ovarian cancer-associated mesothelial cells

    • Principal Investigator
      Kajiyama Hiroaki
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  Analysis of tumor-infiltrating lymphocytes in malignant gynecologic tumors for development of personalized tumor immunotherapy

    • Principal Investigator
      Kikkawa Fumitaka
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  Analyses of tumor heterogeneity and peritoneal tumor microenvironment in ovarian cancer for development of novel tumor immunotherapyPrincipal Investigator

    • Principal Investigator
      SUZUKI Shiro
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  An attempt to identify new antigens recognized by tumor-specific cytotoxic T lymphocytes using a HLA-modified ovarian cancer cell line as an artificial antigen presenting cell

    • Principal Investigator
      KIKKAWA Fumitaka
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  Immunological and clinical analysis of tumor antigen specific immunotherapy combined with chemotherapy against ovarian cancerPrincipal Investigator

    • Principal Investigator
      SUZUKI Shiro
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University

All 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

  • [Journal Article] Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?2021

    • Author(s)
      Ukai Mayu、Suzuki Shiro、Yoshihara Masato、Yokoi Akira、Yoshikawa Nobuhisa、Kajiyama Hiroaki、Kikkawa Fumitaka
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 27 Issue: 3 Pages: 609-618

    • DOI

      10.1007/s10147-021-02075-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-20K22806, KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-20H03824, KAKENHI-PROJECT-21H03075
  • [Journal Article] The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer2021

    • Author(s)
      SHIMIZU YUSUKE、SUZUKI SHIRO、UKAI MAYU、HATTORI SATOMI、YOSHIKAWA NOBUHISA、KAJIYAMA HIROAKI
    • Journal Title

      Anticancer Research

      Volume: 41 Issue: 1 Pages: 249-258

    • DOI

      10.21873/anticanres.14771

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09778, KAKENHI-PROJECT-19K18693
  • [Journal Article] Achievement of live birth after overcoming two gynecological malignancies treated with radical trachelectomy and medroxyprogesterone acetate therapy2021

    • Author(s)
      Tamauchi Satoshi、Moriyama Yoshinori、Suzuki Shiro、Ikeda Yoshiki、Yoshikawa Nobuhisa、Kajiyama Hiroaki
    • Journal Title

      Journal of Obstetrics and Gynaecology Research

      Volume: 47 Issue: 11 Pages: 4101-4105

    • DOI

      10.1111/jog.15001

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H03797
  • [Journal Article] Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance2021

    • Author(s)
      Yoshida Kosuke、Yokoi Akira、Sugiyama Mai、Oda Shingo、Kitami Kazuhisa、Tamauchi Satoshi、Ikeda Yoshiki、Yoshikawa Nobuhisa、Nishino Kimihiro、Niimi Kaoru、Suzuki Shiro、Kikkawa Fumitaka、Yokoi Tsuyoshi、Kajiyama Hiroaki
    • Journal Title

      Oncogene

      Volume: 40 Issue: 7 Pages: 1255-1268

    • DOI

      10.1038/s41388-020-01595-3

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K22806, KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-19K18693
  • [Journal Article] Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer2021

    • Author(s)
      NOSAKA KAZUTO、SUZUKI SHIRO、YOSHIKAWA TOSHIAKI、SHIMOMURA MANAMI、KITAMI KAZUHISA、YOSHIDA KOSUKE、YOSHIHARA MASATO、KIKKAWA FUMITAKA、NAKATSURA TETSUYA、KAJIYAMA HIROAKI
    • Journal Title

      Anticancer Research

      Volume: 41 Issue: 10 Pages: 4741-4751

    • DOI

      10.21873/anticanres.15289

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-20H03824
  • [Journal Article] Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer2021

    • Author(s)
      Hattori Satomi、Yoshikawa Nobuhisa、Mogi Kazumasa、Yoshida Kosuke、Yoshihara Masato、Tamauchi Satoshi、Ikeda Yoshiki、Yokoi Akira、Nishino Kimihiro、Niimi Kaoru、Suzuki Shiro、Kajiyama Hiroaki
    • Journal Title

      Current Oncology

      Volume: 28 Issue: 3 Pages: 1663-1672

    • DOI

      10.3390/curroncol28030155

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-20K22806, KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-20H03824
  • [Journal Article] Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma2021

    • Author(s)
      Ukai Mayu、Yokoi Akira、Yoshida Kosuke、Suzuki Shiro、Shibata Kiyosumi、Kikkawa Fumitaka、Nakatsura Tetsuya、Kajiyama Hiroaki
    • Journal Title

      Cancers

      Volume: 13 Issue: 3 Pages: 550-550

    • DOI

      10.3390/cancers13030550

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K22806, KAKENHI-PROJECT-19H03797
  • [Journal Article] Impact of uterus‐preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi‐institutional study with propensity score‐weighted analysis2020

    • Author(s)
      Yoshihara Masato、Kajiyama Hiroaki、Tamauchi Satoshi、Iyoshi Shohei、Yokoi Akira、Suzuki Shiro、Kawai Michiyasu、Nagasaka Tetsuro、Takahashi Kunihiko、Matsui Shigeyuki、Kikkawa Fumitaka
    • Journal Title

      International Journal of Gynecology & Obstetrics

      Volume: 150 Issue: 2 Pages: 177-183

    • DOI

      10.1002/ijgo.13244

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-20H03824, KAKENHI-PROJECT-16H06299
  • [Journal Article] CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway2020

    • Author(s)
      Hiroaki Yasui, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Yang Peng, Nobuhisa Yoshikawa, Mai Sugiyama, Kae Nakamura, Fumitaka Kikkawa
    • Journal Title

      Clinical & Experimental Metastasis

      Volume: 37 Pages: 145-158

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Journal Article] CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.2020

    • Author(s)
      Yasui H, Kajiyama H, Tamauchi S, Suzuki S, Peng Y, Yoshikawa N, Sugiyama M, Nakamura K, Kikkawa F.
    • Journal Title

      Clin Exp Metastasis.

      Volume: 37 Issue: 1 Pages: 141-158

    • DOI

      10.1007/s10585-019-09993-y

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H05462, KAKENHI-PROJECT-17H04338
  • [Journal Article] The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma2020

    • Author(s)
      Kajiyama Hiroaki、Suzuki Shiro、Yoshikawa Nobuhisa、Tamauchi Satoshi、Shibata Kiyosumi、Kikkawa Fumitaka
    • Journal Title

      Journal of Gynecologic Oncology

      Volume: 31 Issue: 4

    • DOI

      10.3802/jgo.2020.31.e47

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H05462, KAKENHI-PROJECT-19H03797
  • [Journal Article] The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage Ovarian Clear Cell Carcinoma2020

    • Author(s)
      Yoshikawa Nobuhisa、Yoshida Kosuke、Tamauchi Satoshi、Ikeda Yoshiki、Nishino Kimihiro、Niimi Kaoru、Suzuki Shiro、Kikkawa Fumitaka、Kajiyama Hiroaki
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 7135-7135

    • DOI

      10.1038/s41598-020-64171-5

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H03797
  • [Journal Article] Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy2020

    • Author(s)
      Nakao Yuri、Tamauchi Satoshi、Yoshikawa Nobuhisa、Suzuki Shiro、Kajiyama Hiroaki、Kikkawa Fumitaka
    • Journal Title

      Case Reports in Oncology

      Volume: 13 Issue: 1 Pages: 373-378

    • DOI

      10.1159/000506446

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Journal Article] Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer2020

    • Author(s)
      Yoshikawa Nobuhisa、Shirakawa Akira、Yoshida Kosuke、Tamauchi Satoshi、Suzuki Shiro、Kikkawa Fumitaka、Kajiyama Hiroaki
    • Journal Title

      Nutrition in Clinical Practice

      Volume: - Issue: 6 Pages: 1041-1046

    • DOI

      10.1002/ncp.10482

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19K09778, KAKENHI-PROJECT-19H03797
  • [Journal Article] Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.2020

    • Author(s)
      Yoshihara M, Kajiyama H, Yokoi A, Sugiyama M, Koya Y, Yamakita Y, Liu W, Nakamura K, Moriyama Y, Yasui H, Suzuki S, Yamamoto Y, Ricciardelli C, Nawa A, Shibata K, Kikkawa F
    • Journal Title

      Int J Cancer

      Volume: 146 Issue: 8 Pages: 2268-2280

    • DOI

      10.1002/ijc.32854

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19K09751, KAKENHI-PROJECT-20K22806, KAKENHI-PROJECT-19H03797, KAKENHI-PROJECT-20H03824
  • [Journal Article] Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma2020

    • Author(s)
      Kajiyama Hiroaki、Suzuki Shiro、Shimbo Akiko、Utsumi Fumi、Yoshikawa Nobuhisa、Kikkawa Fumitaka
    • Journal Title

      Journal of Palliative Medicine

      Volume: 23 Issue: 8 Pages: 1060-1065

    • DOI

      10.1089/jpm.2019.0456

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Journal Article] Establishment of a patient‐derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary2020

    • Author(s)
      Tamauchi Satoshi、Suzuki Shiro、Xuboya Chang、Yoshihara Masato、Yoshida Kosuke、Ikeda Yoshiki、Yoshikawa Nobuhisa、Kajiyama Hiroaki、Kikkawa Fumitaka
    • Journal Title

      Journal of Obstetrics and Gynaecology Research

      Volume: 47 Issue: 2 Pages: 713-719

    • DOI

      10.1111/jog.14596

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H03797
  • [Journal Article] Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.2019

    • Author(s)
      Kajiyama H, Suzuki S, Yoshikawa N, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      Eur J Obstet Gynecol Reprod Biol.

      Volume: 印刷中 Pages: 131-136

    • DOI

      10.1016/j.ejogrb.2019.01.009

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-16K08688, KAKENHI-PROJECT-15H02660
  • [Journal Article] Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.2019

    • Author(s)
      Kajiyama H, Suzuki S, Yoshikawa N, Kawai M, Shibata K, Nagasaka T, Kikkawa F.
    • Journal Title

      Int J Gynecol Cancer

      Volume: - Issue: 5 Pages: 910-915

    • DOI

      10.1136/ijgc-2018-000142

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19H05462
  • [Journal Article] Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma2019

    • Author(s)
      Shimbo Akiko、Kajiyama Hiroaki、Tamauchi Satoshi、Yoshikawa Nobuhisa、Ikeda Yoshiki、Nishino Kimihiro、Suzuki Shiro、Niimi Kaoru、Sakata Jun、Kikkawa Fumitaka
    • Journal Title

      Oncology Reports

      Volume: 42(6) Pages: 2323-2332

    • DOI

      10.3892/or.2019.7352

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K16795, KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H05462, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19H03797
  • [Journal Article] Interleukin?33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis2019

    • Author(s)
      Sekiya Atsushi、Suzuki Shiro、Tanaka Ayako、Hattori Satomi、Shimizu Yusuke、Yoshikawa Nobuhisa、Koya Yoshihiro、Kajiyama Hiroaki、Kikkawa Fumitaka
    • Journal Title

      International Journal of Oncology

      Volume: - Pages: 755-765

    • DOI

      10.3892/ijo.2019.4845

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H05462, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19H03797
  • [Journal Article] Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.2019

    • Author(s)
      Kajiyama H, Suzuki S, Niimi K, Tamauchi S, Kawai M, Nagasaka T, Shibata K, Kikkawa F.
    • Journal Title

      Int J Clin Oncol

      Volume: - Issue: 7 Pages: 857-862

    • DOI

      10.1007/s10147-019-01416-y

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19H05462
  • [Journal Article] Unique miRNA profiling of squamous cell carcinoma arising from ovarian mature teratoma: comprehensive miRNA sequence analysis of its molecular background2019

    • Author(s)
      Yoshida Kosuke、Yokoi Akira、Kagawa Takumi、Oda Shingo、Hattori Satomi、Tamauchi Satoshi、Ikeda Yoshiki、Yoshikawa Nobuhisa、Nishino Kimihiro、Utsumi Fumi、Niimi Kaoru、Suzuki Shiro、Shibata Kiyosumi、Kajiyama Hiroaki、Yokoi Tsuyoshi、Kikkawa Fumitaka
    • Journal Title

      Carcinogenesis

      Volume: 40 Pages: 1435-1444

    • DOI

      10.1093/carcin/bgz135

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18693, KAKENHI-PROJECT-19H05462, KAKENHI-PROJECT-15H02660, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-19H03797
  • [Journal Article] PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.2019

    • Author(s)
      Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, Fujikake K, Yasui H, Yoshikawa N, Suzuki S, Senga T, Shibata K, Kikkawa F.
    • Journal Title

      Cancer Lett

      Volume: 442 Pages: 181-192

    • DOI

      10.1016/j.canlet.2018.10.027

    • NAID

      120006623836

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H06753
  • [Journal Article] Endometriosis and cancer.2019

    • Author(s)
      Kajiyama H, Suzuki S, Yoshihara M, Tamauchi S, Yoshikawa N, Niimi K, Shibata K, Kikkawa F.
    • Journal Title

      Free Radic Biol Med.

      Volume: 133 Pages: 186-192

    • DOI

      10.1016/j.freeradbiomed.2018.12.015

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15H02660
  • [Journal Article] Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.2019

    • Author(s)
      Kajiyama H, Suzuki S, Utsumi F, Yoshikawa N, Nishino K, Ikeda Y, Niimi K, Yamamoto E, Kawai M, Shibata K, Nagasaka T, Kikkawa F.
    • Journal Title

      Int J Clin Oncol.

      Volume: 印刷中 Issue: 8 Pages: 950-956

    • DOI

      10.1007/s10147-019-01438-6

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-16K08688, KAKENHI-PROJECT-19H05462
  • [Journal Article] Relationship between preexisting mental disorders and prognosis of gynecologic cancers: A case-control study.2019

    • Author(s)
      Tamauchi S, Kajiyama H, Moriyama Y, Yoshihara M, Ikeda Y, Yoshikawa N, Nishino K, Niimi K, Suzuki S, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res

      Volume: 45(10) Issue: 10 Pages: 2082-2087

    • DOI

      10.1111/jog.14053

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Journal Article] A post-recurrence survival?predicting indicator for cervical cancer from the analysis of 165???patients who developed recurrence2018

    • Author(s)
      Yoshida Kosuke、Kajiyama Hiroaki、Utsumi Fumi、Niimi Kaoru、Sakata Jun、Suzuki Shiro、Shibata Kiyosumi、Kikkawa Fumitaka
    • Journal Title

      Molecular and Clinical Oncology

      Volume: 8 Pages: 1-5

    • DOI

      10.3892/mco.2017.1530

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338
  • [Journal Article] The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours2018

    • Author(s)
      Kajiyama Hiroaki、Suzuki Shiro、Yoshihara Masato、Nishino Kimihiro、Yoshikawa Nobuhisa、Utsumi Fumi、Niimi Kaoru、Mizuno Mika、Kawai Michiyasu、Oguchi Hidenori、Mizuno Kimio、Yamamuro Osamu、Nagasaka Tetsuro、Shibata Kiyosumi、Kikkawa Fumitaka
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 5 Pages: 6298-6307

    • DOI

      10.18632/oncotarget.23921

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15K20138
  • [Journal Article] The upregulated expression of vascular endothelial growth factor in surgically treated patients with recurrent/radioresistant cervical cancer of the uterus.2018

    • Author(s)
      Yoshida K, Suzuki S, Sakata J, Utsumi F, Niimi K, Yoshikawa N, Nishino K, Shibata K, Kikkawa F, Kajiyama H.
    • Journal Title

      Oncol Lett

      Volume: 16(1) Pages: 515-521

    • DOI

      10.3892/ol.2018.8610

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H06753
  • [Journal Article] Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas2018

    • Author(s)
      Nakamura Kenichi、Kajiyama Hiroaki、Utsumi Fumi、Suzuki Shiro、Niimi Kaoru、Sekiya Ryuichiro、Sakata Jun、Yamamoto Eiko、Shibata Kiyosumi、Kikkawa Fumitaka
    • Journal Title

      Molecular and Clinical Oncology

      Volume: 8 Pages: 499-503

    • DOI

      10.3892/mco.2018.1560

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15K20136
  • [Journal Article] KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells.2018

    • Author(s)
      Kawai Y, Shibata K, Sakata J, Suzuki S, Utsumi F, Niimi K, Sekiya R, Senga T, Kikkawa F, Kajiyama H.
    • Journal Title

      Oncol Rep

      Volume: 40(1) Pages: 195-205

    • DOI

      10.3892/or.2018.6401

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Journal Article] Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator2017

    • Author(s)
      Sakata Jun、Kajiyama Hiroaki、Suzuki Shiro、Utsumi Fumi、Niimi Kaoru、Sekiya Ryuichiro、Shibata Kiyosumi、Senga Takeshi、Kikkawa Fumitaka
    • Journal Title

      Oncology Letters

      Volume: 14 Issue: 4 Pages: 4287-4293

    • DOI

      10.3892/ol.2017.6658

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15K20136, KAKENHI-PROJECT-15K20138
  • [Journal Article] A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer2017

    • Author(s)
      Fujikake Kayo、Kajiyama Hiroaki、Yoshihara Masato、Nishino Kimihiro、Yoshikawa Nobuhisa、Utsumi Fumi、Suzuki Shiro、Niimi Kaoru、Sakata Jun、Mitsui Hiroko、Shibata Kiyosumi、Senga Takeshi、Kikkawa Fumitaka
    • Journal Title

      Oncology Reports

      Volume: 39 Pages: 193-200

    • DOI

      10.3892/or.2017.6104

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15K10714, KAKENHI-PROJECT-15K20138
  • [Journal Article] Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells2017

    • Author(s)
      Sakata Jun、Utsumi Fumi、Suzuki Shiro、Niimi Kaoru、Yamamoto Eiko、Shibata Kiyosumi、Senga Takeshi、Kikkawa Fumitaka、Kajiyama Hiroaki
    • Journal Title

      Oncotarget

      Volume: 8 Issue: 59 Pages: 99482-99494

    • DOI

      10.18632/oncotarget.20107

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-17H04338, KAKENHI-PROJECT-15K20138
  • [Journal Article] Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer.2017

    • Author(s)
      Utsumi F, Kajiyama H, Niimi K, Sekiya R, Sakata J, Suzuki S, Shibata K, Mizuno M, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res.

      Volume: 43 Issue: 2 Pages: 365-370

    • DOI

      10.1111/jog.13219

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-15K20136, KAKENHI-PROJECT-15K20138
  • [Journal Article] Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.2016

    • Author(s)
      Suzuki S, Sakata J, Utsumi F, Sekiya R, Kajiyama H, Shibata K, Kikkawa F, Nakatsura T.
    • Journal Title

      Oncoimmunology

      Volume: 5 Issue: 11 Pages: e1238542-e1238542

    • DOI

      10.1080/2162402x.2016.1238542

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-15K15604, KAKENHI-PROJECT-15K10714, KAKENHI-PROJECT-15K20138
  • [Journal Article] Feasibility and benefit of concurrent chemoradiotherapy for elderly patients with uterine cervical cancer.2016

    • Author(s)
      Nosaka K, Shibata K, Utsumi F, Yoshida K, Niimi K, Sekiya R, Suzuki S, Kajiyama H, Kikkawa F.
    • Journal Title

      Tumori

      Volume: 102 Issue: 6 Pages: 600-605

    • DOI

      10.5301/tj.5000530

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-16H05472, KAKENHI-PROJECT-15K20136
  • [Journal Article] PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.2016

    • Author(s)
      Yoshikawa N, Kajiyama H, Nakamura K, Utsumi F, Niimi K, Mitsui H, Sekiya R, Suzuki S, Shibata K, Callen D, Kikkawa F.
    • Journal Title

      Oncol Rep

      Volume: 35(5) Issue: 5 Pages: 2543-52

    • DOI

      10.3892/or.2016.4653

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25293341, KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-15K15604, KAKENHI-PROJECT-15K20136, KAKENHI-PROJECT-15K20138
  • [Journal Article] Opioid needs of terminally ill patients with gynecologic malignancies.2015

    • Author(s)
      Utsumi F, Kajiyama H, Sakata J, Higashi M, Niimi K, Sekiya R, Mitsui H, Suzuki S, Umezu T, Mizuno M, Yamamoto E, Shibata K, Kikkawa F
    • Journal Title

      Int J Clin Oncol.

      Volume: 20 Issue: 2 Pages: 405-10

    • DOI

      10.1007/s10147-014-0708-0

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-15K20138
  • [Journal Article] The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study.2015

    • Author(s)
      Adachi M, Mizuno M, Mitsui H, Kajiyama H, Suzuki S, Sekiya R, Utsumi F, Shibata K, Taniguchi T, Kawaguchi K, Yokoi K, Kikkawa F.
    • Journal Title

      Nagoya J Med Sci

      Volume: 77(3) Pages: 363-72

    • NAID

      120005649103

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Journal Article] Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs.2015

    • Author(s)
      Yamada E, Demachi-Okamura A, Kondo S, Akatsuka Y, Suzuki S, Shibata K, Kikkawa F, Kuzushima K.
    • Journal Title

      Tissue Antigens

      Volume: 86(3) Issue: 3 Pages: 164-71

    • DOI

      10.1111/tan.12607

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K20138, KAKENHI-PROJECT-25871227
  • [Journal Article] GPC3 expression in mouse ovarian cancer induces GPC-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.2014

    • Author(s)
      Luo C, Shibata K, Suzuki S, Kajiyama H, Senga T, Koya Y, Daimon M, Yamashita M, Kikkawa F.
    • Journal Title

      Oncol Rep.

      Volume: 32 Issue: 3 Pages: 913-21

    • DOI

      10.3892/or.2014.3300

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-24390380, KAKENHI-PROJECT-24659727, KAKENHI-PROJECT-24791698, KAKENHI-PROJECT-25293341, KAKENHI-PROJECT-25670701
  • [Journal Article] Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells.2014

    • Author(s)
      Kumazawa S, Kajiyama H, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Shibata K, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res.

      Volume: 40(5) Pages: 1389-1398

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Journal Article] Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology.2014

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Sekiya R, Niimi K, Mitsui H, Yamamoto E, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      J Gynecol Oncol.

      Volume: 25 Issue: 1 Pages: 43-50

    • DOI

      10.3802/jgo.2014.25.1.43

    • Peer Reviewed
    • Data Source
      KAKENHI-ORGANIZER-24108001, KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-24390380, KAKENHI-PROJECT-24791698, KAKENHI-PROJECT-25293341, KAKENHI-PROJECT-25670701, KAKENHI-PROJECT-25893093
  • [Journal Article] Is there any association between where patients spend the end of life and survival after anticancer treatment for gynecologic malignancy?2014

    • Author(s)
      Kajiyama H, Utsumi F, Higashi M, Sakata J, Sekiya R, Mizuno M, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Niimi K, Shibata K, Kikkawa F.
    • Journal Title

      J Palliat Med.

      Volume: 17 Issue: 3 Pages: 325-30

    • DOI

      10.1089/jpm.2013.0366

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-24791698, KAKENHI-PROJECT-25670701
  • [Journal Article] Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?2014

    • Author(s)
      Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      Eur J Obstet Gynecol Reprod Biol.

      Volume: 181 Pages: 305-310

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Journal Article] Oncologic Outcome after Recurrence in Patients with Stage I Epithelial Ovarian Cancer: ~Are Clear-cell and Mucinous Histological Types a Different Entities?2014

    • Author(s)
      Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya, R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      Eur J Obstet Gynecol Reprod Biol.

      Volume: 181 Pages: 305-10

    • DOI

      10.1016/j.ejogrb.2014.07.046

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-24108008, KAKENHI-PROJECT-24791698, KAKENHI-PROJECT-25293341
  • [Journal Article] Opioid needs of terminally ill patients with gynecologic malignancies.2014

    • Author(s)
      Utsumi F, Kajiyama H, Sakata J, Higashi M, Niimi K, Sekiya R, Mitsui H, Suzuki
    • Journal Title

      Int J Clin Oncol.

      Volume: Epub ahead of print

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Journal Article] Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports.2013

    • Author(s)
      Suzuki S, Shibata K, Kikkawa F, Nakatsura T
    • Journal Title

      Hum Vaccin Immunother

      Volume: 19;10(2) Issue: 2 Pages: 338-343

    • DOI

      10.4161/hv.27217

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24592512, KAKENHI-PROJECT-24659727, KAKENHI-PROJECT-24791698
  • [Journal Article] The expression and characterization of endoglin in uterine leiomyosarcoma.2013

    • Author(s)
      Mitsui H, Shibata K, Mano Y, Suzuki S, Umezu T, Mizuno M, Yamamoto E, Kajiyama H, Kotani T, Senga T, Kikkawa F.
    • Journal Title

      Clin Exp Metastasis.

      Volume: Epub ahead of print

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Journal Article] Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.2013

    • Author(s)
      Nobuoka D, Yoshikawa T, Takahashi M, Iwama T, Horie K, Shimomura M, Suzuki S, Sakemura N, Nakatsugawa M, Sadamori H, Yagi T, Fujiwara T, Nakatsura T
    • Journal Title

      Cancer Immunol Immunother

      Volume: 62(4) Issue: 4 Pages: 639-652

    • DOI

      10.1007/s00262-012-1366-6

    • NAID

      120005315577

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591864, KAKENHI-PROJECT-24791698
  • [Journal Article] Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.2012

    • Author(s)
      Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F.
    • Journal Title

      Hum Pathol.

      Volume: 44 Issue: 2 Pages: 181-188

    • DOI

      10.1016/j.humpath.2012.05.015

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23592445, KAKENHI-PROJECT-24791698
  • [Journal Article] Postrecurrent oncologic outcome of patients with ovarian clear cell carcinoma.2012

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Yamamoto E, Fujiwara S, Umezu T, Suzuki S, Nakanishi T, Nagasaka T, Kikkawa F.
    • Journal Title

      Int J Gynecol Cancer.

      Volume: 22 Issue: 5 Pages: 801-806

    • DOI

      10.1097/igc.0b013e3182540145

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23592445, KAKENHI-PROJECT-24791698, KAKENHI-PLANNED-24108008
  • [Journal Article] Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?2012

    • Author(s)
      Sakai K, Kajiyama H, Umezu T, Shibata K, Mizuno M, Suzuki S, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res.

      Volume: 38(7) Issue: 7 Pages: 1018-23

    • DOI

      10.1111/j.1447-0756.2011.01826.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Epigenetic modification of antitumor T cells to induce durable clinical response in adoptive immunotherapy2021

    • Author(s)
      吉川聡明, ウー チィウェン, 松下 博和, 細田 和貴, 鈴木 史朗, 籠谷 勇紀
    • Organizer
      第25回日本がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] リンチ症候群に対する大腸癌と子宮内膜癌の手術症例を対象にしたユニバーサルスクリーニングの取り組み2021

    • Author(s)
      高磯 伸枝, 福江 美咲, 小森 康司, 鈴木 史朗, 清水 泰博, 井本 逸勢
    • Organizer
      第45回日本遺伝カウンセリング学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] エピジェネティック因子修飾による抗腫瘍T細胞の機能改善2021

    • Author(s)
      吉川聡明, ウー チィウェン, 松下 博和, 鈴木 史朗, 籠谷 勇紀
    • Organizer
      第18回日本免疫治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] 当院における高頻度マイクロサテライト不安定性を有する固形癌症例とペンブロリズマブ投与後の報告2021

    • Author(s)
      新保 暁子, 大野 真由, 玉内 学志, 池田 芳紀, 芳川 修久, 西野 公博, 新美 薫, 鈴木 史朗, 梶山 広明, 吉川 史隆
    • Organizer
      第62回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] Type2子宮体癌における帯状リンパ組織様構造の存在は良好な予後と関連する2020

    • Author(s)
      鈴木史朗, 清水裕介, 服部諭美, 吉川史隆
    • Organizer
      第17回日本免疫治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] 早期の卵巣明細胞癌における予後因子としての好中球リンパ球比および血小板リンパ球比の検討2019

    • Author(s)
      吉田康将,芳川修久,白川 晶,玉内学志,池田芳紀,西野公博,新美 薫,鈴木史朗,梶山広明,吉川史隆
    • Organizer
      第61回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Presentation] Identification of cancer specific miRNA in squamous cell carcinoma arising from mature teratoma of ovary using next-generation sequencing.2019

    • Author(s)
      Yoshida K, Yokoi A, Ikeda Y, Yoshikawa N, Nishino K, Niimi K, Suzuki S, Kajiyama H, Kikkawa F
    • Organizer
      第71 回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Presentation] Identification of unique miRNA profiling in squamous cell carcinoma arising from mature teratoma of ovary2019

    • Author(s)
      Yoshida K, Yokoi A, Tamauchi S, Yoshihara M, Yoshikawa N, Nishino K, Niimi K, Suzuki S, Kajiyama H, Kikkawa F
    • Organizer
      第78 回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Presentation] 婦人科がんに対する複合的がん免疫療法の開発を目指した基盤研究2019

    • Author(s)
      鈴木史朗
    • Organizer
      第71回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09778
  • [Presentation] 婦人科がんの腫瘍浸潤リンパ球における腫瘍反応性CTLの抽出法の開発とそれらが認識する抗原の同定2019

    • Author(s)
      野坂和外, 吉川聡明, 鈴木利宙, 齋藤桂吾, 下村真菜美, 水野正一, 鈴木史朗, 吉川史隆, 中面哲也
    • Organizer
      第16回日本免疫治療学研究会学術集会
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] Comprehensive miRNA sequencing of squamous cell caricinoma arising from ovarian mature teratoma2019

    • Author(s)
      Yoshida K, Yokoi A, Tamauchi S, Ikeda Y, Yoshikawa N, Nishino K, Niimi K, Suzuki S, Kajiyama H, Kikkawa F
    • Organizer
      21st European Congress on Gynaecological Oncology (ESGO)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03797
  • [Presentation] A long non-coding RNA "LUCAT1" mediates taxane-resistance acquisition in ovarian cancer2018

    • Author(s)
      Tamauchi S, S, Kajiyama H, Yoshikawa N, Utsumi F, Suzuki S, Kikkawa F
    • Organizer
      第70回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17H04338
  • [Presentation] 婦人科がんにおける個別化免疫療法の開発2018

    • Author(s)
      野坂 和外, 吉川 聡明, 鈴木 利宙, 齋藤 桂吾, 下村 真菜美, 水野 正一, 鈴木 史朗, 吉川 史隆, 中面 哲也
    • Organizer
      第15回日本免疫治療学研究会学術集会
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] 婦人科がんにおける個別化免疫療法の開発2018

    • Author(s)
      野坂 和外, 吉川 聡明, 鈴木 利宙, 齋藤 桂吾, 下村 真菜美, 水野 正一, 鈴木 史朗, 吉川 史隆, 中面 哲也
    • Organizer
      第15回日本免疫治療学研究会学術集会
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 卵巣癌におけるIL-33に着目した腹腔内免疫環境の基礎的・臨床的研究2018

    • Author(s)
      関谷 敦史, 鈴木 史朗, 清水 裕介, 芳川 修久, 坂田 純, 内海 史, 梶山 広明, 吉川 史隆
    • Organizer
      第70回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 照射野内再発子宮頸癌でのVEGF発現検討2018

    • Author(s)
      吉田康将、梶山広明、芳川修久、西野公博、内海史、新美薫、鈴木史朗、吉川史隆
    • Organizer
      第6回 婦人科がんバイオマーカー研究会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04338
  • [Presentation] Does prophylactic irradiation to para-aortic lymph node lead to the positive effects for uterine cervical cancer? ~ a retrospective propensity score adjusted study ~2017

    • Author(s)
      Kosuke Yoshida, Hiroaki Kajiyama, Masato Yoshihara, Jun Sakata, Fumi Utsumi, Kaoru Niimi, Ryuichiro Sekiya, Shiro Suzuki, Kiyosumi Shibata, Fumitaka Kikkawa
    • Organizer
      第69回 日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17H04338
  • [Presentation] 婦人科がんpatient-derived xenograftモデルの構築2017

    • Author(s)
      鈴木 史朗, 坂田 純, 内海 史, 関谷 龍一郎, 梶山 広明, 柴田 清住, 吉川 史隆
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 婦人科がんpatient-derived xenograftモデルの構築2017

    • Author(s)
      鈴木 史朗, 坂田 純, 内海 史, 関谷 龍一郎, 梶山 広明, 柴田 清住, 吉川 史隆
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] ESTABLISHMENT AND CHARACTERISATION OF PATIENT-DERIVED XENOGRAFT MODELS FOR MALIGNANT GYNECOLOGIC TUMORS2017

    • Author(s)
      鈴木 史朗, 玉内 学志, 清水 裕介, 吉原 雅人, 中村 謙一, 芳川 修久, 梶山 広明, 吉川 史隆
    • Organizer
      20th Biennial Meeting of the European Society of Gynaecological Oncology (ESGO 2017)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] ESTABLISHMENT AND CHARACTERISATION OF PATIENT-DERIVED XENOGRAFT MODELS FOR MALIGNANT GYNECOLOGIC TUMORS2017

    • Author(s)
      鈴木 史朗, 玉内 学志, 清水 裕介, 吉原 雅人, 中村 謙一, 芳川 修久, 梶山 広明, 吉川 史隆
    • Organizer
      20th Biennial Meeting of the European Society of Gynaecological Oncology (ESGO 2017)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] 再発子宮頸癌におけるVEGF発現の検討2017

    • Author(s)
      吉田康将、芳川修久、西野公博、坂田純、内海史、新美薫、鈴木史朗、梶山広明、吉川史隆
    • Organizer
      第59回 日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17H04338
  • [Presentation] 抗癌剤耐性再発卵巣癌における耐性能の可逆性とDrug-rechallengeへの応答2017

    • Author(s)
      坂田 純, 梶山 広明, 内海 史, 新美 薫, 関谷 龍一郎, 鈴木 史朗, 柴田 清住, 吉川 史隆
    • Organizer
      第59回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 再発子宮頸癌におけるVEGFの発現、およびベバシズマブ併用療法の有用性の検討2017

    • Author(s)
      吉田康将、芳川修久、西野公博、坂田純、内海史、新美薫、鈴木史朗、梶山広明、吉川史隆
    • Organizer
      第55回 日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04338
  • [Presentation] Prognostic factors for patients with clear cell adenocarcinoma of the ovary at reproductive age2016

    • Author(s)
      吉原 雅人, 玉内 学志, 藤掛 佳代, 関谷 敦史, 関谷 龍一郎, 鈴木 史郎, 柴田 清住, 吉川 史隆
    • Organizer
      日本癌治療学会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-10-21
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] A recurrence-predicting prognostic factor for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery2016

    • Author(s)
      梶山 広明,柴田 清住, 坂田 純, 内海 史, 新美 薫, 関谷 龍一郎, 鈴木 史朗, 藤掛 佳代, 吉原 雅人, 関谷 敦史, 玉内 学志, 吉川 史隆
    • Organizer
      日本癌治療学会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-10-21
    • Data Source
      KAKENHI-PROJECT-16H05472
  • [Presentation] 抗癌剤耐性ヒト卵巣癌細胞株における5-アミノレブリン酸を用いた光線力学療法の検討2016

    • Author(s)
      勅使河原 利哉, 水野 美香, 石井 琢也, 三井 寛子, 内海 史, 関谷 龍一郎, 鈴木 史朗, 梶山 広明, 柴田 清住, 高橋 究, 石塚 昌宏, 吉川 史隆
    • Organizer
      第58回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      米子コンベンションセンター(鳥取県米子市)
    • Year and Date
      2016-07-08
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 卵巣明細胞腺癌に対するGPC3を標的としたペプチドワクチン療法 ~臨床第Ⅱ相試験のデータ解析から見える今後の課題~2016

    • Author(s)
      鈴木 史朗, 柴田 清住, 吉川 史隆, 中面 哲也
    • Organizer
      第20回日本がん免疫学会総会
    • Place of Presentation
      大阪国際交流センター(大阪府大阪市天王寺区)
    • Year and Date
      2016-07-27
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 卵巣癌における新規腫瘍抗原KIF20A発現の検討とペプチドカクテルワクチン療法への臨床応用2016

    • Author(s)
      河合要介, 鈴木史朗, 梶山広明, 柴田清住, 吉川史隆
    • Organizer
      第20回日本がん免疫学会総会
    • Place of Presentation
      大阪国際交流センター(大阪府大阪市天王寺区)
    • Year and Date
      2016-07-27
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] A biomarker analysis in a clinical study of the GPC3 peptide vaccine for patients with ovarian clear cell carcinoma2015

    • Author(s)
      鈴木史朗, 柴田清住, 吉川史隆, 中面哲也
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県名古屋市)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] ミニワークショップ5:卵巣明細胞腺癌患者におけるHLA-Aアリル多型性の検討2015

    • Author(s)
      鈴木史朗, 内海史, 三井寛子, 関谷龍一郎, 梶山広明, 柴田清住, 吉川史隆
    • Organizer
      第57回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      いわて県民情報交流センター(岩手県盛岡市)
    • Year and Date
      2015-08-07
    • Data Source
      KAKENHI-PROJECT-15K20138
  • [Presentation] 卵巣明細胞腺癌に対するGlypican-3ペプチドワクチン療法の臨床的・免疫学的検討 ~臨床的寛解が得られた症例に対するAdjuvant therapyに関して~2014

    • Author(s)
      鈴木史朗、柴田清住、中面哲也
    • Organizer
      第11回日本免疫治療学研究会学術集会
    • Place of Presentation
      東京ガーデンパレス、東京都文京区
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] ワークショップ2:卵巣明細胞腺癌の予後改善を目指して 進行卵巣明細胞腺癌に対するGlypican3 ペプチドワクチン療法 ~抗腫瘍効果が得られた2 例を中心に~2013

    • Author(s)
      鈴木史朗、柴田清住、梅津朋和、水野美香、梶山広明、吉川史隆、中面哲也
    • Organizer
      第54回 日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      ホテル グランパシフィック LE DAIBA(東京都港区)
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] Clinical and immunological analysis in a phase II trial of the Glypican-3 peptide vaccine for ovarian clear cell carcinoma patients2013

    • Author(s)
      鈴木史朗、柴田清住、三井寛子、関谷龍一郎、梅津朋和、水野美香、梶山広明、吉川史隆
    • Organizer
      第3回アジア婦人科腫瘍学会・第55回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      ウェスティン都ホテル京都、京都
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Glypican-3-derived Peptide Vaccine Therapy combined with Chemotherapy against Progressive Ovarian Clear Cell Carcinoma2013

    • Author(s)
      鈴木史朗、柴田清住、吉川史隆、中面哲也
    • Organizer
      1st International Symposium on Immunotherapy
    • Place of Presentation
      London, England
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] 進行卵巣明細胞腺がんに対してGlypican-3ペプチドワクチン療法が有効であった1例2013

    • Author(s)
      鈴木史朗、柴田清住、梅津 朋和、水野 美香、梶山 広明、吉川史隆
    • Organizer
      第65回日本産科婦人科学会学術集会
    • Place of Presentation
      ロイトン札幌、さっぽろ芸文館、札幌プリンスホテルおよび札幌教育文化会館、札幌
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] ワークショップ2:卵巣明細胞腺癌の予後改善を目指して 進行卵巣明細胞腺癌に対するGlypican3 ペプチドワクチン療法 ~抗腫瘍効果が得られた2 例を中心に~2013

    • Author(s)
      鈴木史朗、柴田清住、梅津朋和、水野美香、梶山広明、吉川史隆、中面哲也
    • Organizer
      第54回 日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      ホテルグランパシフィックLE DAIBA、東京都港区
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Glypican-3-derived Peptide Vaccine Therapy combined with Chemotherapy against Progressive Ovarian Clear Cell Carcinoma2013

    • Author(s)
      鈴木史朗、柴田清住、吉川史隆、中面哲也
    • Organizer
      1st International Symposium on Immunotherapy
    • Place of Presentation
      London, England
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.2012

    • Author(s)
      鈴木史朗、芳川修久、水野美香、梶山広明、柴田清住、中面哲也、吉川史隆
    • Organizer
      XX FIGO World Congress of Gynecology and Obstetrics
    • Place of Presentation
      Rome
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.2012

    • Author(s)
      鈴木史朗、芳川修久、水野美香、梶山広明、柴田清住、中面哲也、吉川史隆
    • Organizer
      XX FIGO World Congress of Gynecology and Obstetrics
    • Place of Presentation
      Rome
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] Immune monitoring in clinical study of GPC3 peptide vaccine for patients with ovarian clear cell carcinoma (卵巣明細胞腺癌に対するGPC3ペプチドワクチン療法における免疫モニタリングおよびGPC3ペプチド特異的CTLの誘導)2012

    • Author(s)
      鈴木史朗、柴田清住、吉川聡明、中面哲也、吉川史隆
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌、さっぽろ芸文館、札幌市教育文化会館 札幌市
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] Immune monitoring in clinical study of GPC3 peptide vaccine for patients with ovarian clear cell carcinoma (卵巣明細胞腺癌に対するGPC3ペプチドワクチン療法における免疫モニタリングおよびGPC3ペプチド特異的CTLの誘導)2012

    • Author(s)
      鈴木史朗、柴田清住、吉川聡明、中面哲也、吉川史隆
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌、さっぽろ芸文館、札幌市教育文化会館
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] 卵巣明細胞腺がんを対象としたGlypican-3ペプチドワクチン療法における免疫学的モニタリング2012

    • Author(s)
      鈴木史朗、柴田清住、芳川修久、足立学、山田英里、関谷龍一郎、三井寛子、熊澤詔子、梅津朋和、水野美香、梶山広明、吉川史隆、中面哲也
    • Organizer
      第52回 日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      グランドプリンスホテル新高輪
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] Glypican-3ペプチドワクチン療法により抗腫瘍効果が得られた進行卵巣明細胞腺がんの1例2012

    • Author(s)
      鈴木史朗、柴田清住、中面哲也
    • Organizer
      第25回日本バイオセラピィ学会学術集会
    • Place of Presentation
      倉敷市芸文館
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] 卵巣明細胞腺癌に対してGlypican-3は有効な免疫療法のターゲットとなりうるか?~抗癌剤併用療法の可能性について~2012

    • Author(s)
      鈴木史朗、廣澤友也、柴田清住、吉川史隆
    • Organizer
      第64回日本産科婦人科学会学術集会
    • Place of Presentation
      神戸ポートピアホテル、神戸国際展示場
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] CLINICAL AND IMMUNOLOGICAL ANALYSIS IN CLINICAL STUDY OF GLYPICAN-3 PEPTIDE VACCINE FOR PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA IN FIRST CLINICAL REMISSION

    • Author(s)
      鈴木史朗, 三井寛子, 関谷龍一郎, 水野美香, 梶山広明, 柴田清住, 吉川史隆
    • Organizer
      The 15th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2014)
    • Place of Presentation
      Melbourne(Australia)
    • Year and Date
      2014-11-08 – 2014-11-11
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] CLINICAL AND IMMUNOLOGICAL ANALYSIS IN CLINICAL STUDY OF GLYPICAN-3 PEPTIDE VACCINE FOR PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA IN FIRST CLINICAL REMISSION

    • Author(s)
      鈴木史朗, 三井寛子, 関谷龍一郎, 水野美香, 梶山広明, 柴田清住, 吉川史隆
    • Organizer
      The 15th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2014)
    • Place of Presentation
      Melbourne Convention Exhibition Center, Melbourne, Australia
    • Year and Date
      2014-11-08 – 2014-11-11
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] 臨床的寛解が得られた卵巣明細胞腺癌に対するGlypican-3ペプチドワクチン療法の臨床的・免疫学的検討

    • Author(s)
      鈴木史朗, 柴田清住, 関谷龍一郎, 三井 寛子, 梅津朋和, 水野美香, 梶山広明, 吉川史隆
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム, 東京都千代田区
    • Year and Date
      2014-04-18 – 2014-04-20
    • Data Source
      KAKENHI-PROJECT-24791698
  • [Presentation] 卵巣明細胞腺癌に対する寛解維持Glypican-3 ペプチドワクチン療法の検討

    • Author(s)
      鈴木史朗, 柴田清住, 三井寛子, 関谷龍一郎, 水野美香, 梶山広明, 吉川史隆, 中面哲也
    • Organizer
      第56回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      栃木県総合文化センター(栃木県宇都宮市)
    • Year and Date
      2014-07-17 – 2014-07-19
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] 臨床的寛解が得られた卵巣明細胞腺癌に対するGlypican-3ペプチドワクチン療法の臨床的・免疫学的検討

    • Author(s)
      鈴木史朗, 柴田清住, 関谷龍一郎, 三井 寛子, 梅津朋和, 水野美香, 梶山広明, 吉川史隆
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京都千代田区)
    • Year and Date
      2014-04-18 – 2014-04-20
    • Data Source
      KAKENHI-PROJECT-24659727
  • [Presentation] 卵巣明細胞腺癌に対する寛解維持Glypican-3 ペプチドワクチン療法の検討

    • Author(s)
      鈴木史朗, 柴田清住, 三井寛子, 関谷龍一郎, 水野美香, 梶山広明, 吉川史隆, 中面哲也
    • Organizer
      第56回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      栃木県総合文化センター, 栃木県宇都宮市
    • Year and Date
      2014-07-17 – 2014-07-19
    • Data Source
      KAKENHI-PROJECT-24791698
  • 1.  KIKKAWA Fumitaka (40224985)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 45 results
  • 2.  Kajiyama Hiroaki (00345886)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 41 results
  • 3.  中面 哲也 (30343354)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 13 results
  • 4.  SHIBATA Kiyosumi (90335026)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 27 results
  • 5.  横井 暁 (30737135)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 6 results
  • 6.  芳川 修久 (60804747)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 17 results
  • 7.  SHI Lei
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 7 results
  • 8.  YAMAMOTO Eiko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 9.  SADAMORI Hiroshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 10.  水野 正明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 11.  内海 史
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 5 results
  • 12.  水野 彰
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 13.  田中 昭代
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  坂田 純
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  高橋 英夫
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi